Related by context. All words. (Click for frequent words.) 68 SGLT2 67 ENMD # 66 antiproliferative effects 66 JAK2 inhibitor 66 HepDirect technology 66 cytoprotective 65 targeting PCSK9 65 tubulin inhibitor 65 SERMs 65 selective modulator 65 antisense inhibitors 65 JAK3 65 eprotirome 65 JAK1 65 glucokinase activator 64 CCR9 64 sodium glucose transporter 64 Angiolix 64 selective inhibition 64 VEGF receptor 64 glucagon receptor 63 thromboxane A2 63 Tyrima 63 Vidofludimus 63 RNAi therapeutic targeting 63 immune modulating 63 vidofludimus 63 TRV# [001] 63 insulin sensitizers 63 HepDirect 63 NOX E# 63 Symadex 63 preclinically 63 Anticalins ® 63 MEK inhibitors 63 XL# XL# 63 immunoregulatory 63 HuLuc# 63 Th2 cytokines 63 mGluR2 NAM 62 ATL# [002] 62 CB1 antagonists 62 orally bioavailable mimics 62 CTAP# Capsules 62 ALK inhibitors 62 MEK inhibitor 62 orally administered inhibitor 62 potent antiproliferative 62 neuroprotective properties 62 SGLT2 inhibitors 62 OMP #M# 62 vascular disrupting agents 62 JAK inhibitors 62 selective agonists 62 adenosine A2A 62 Archexin 62 INT# [002] 62 tumor hypoxia 62 ATL# [001] 62 CCR2 62 Remicade infliximab 62 TNFa 62 Carfilzomib 62 PDE4 inhibitor 62 ghrelin antagonist 62 TH# [003] 62 AMPK activators 62 therapeutic monoclonal antibodies 62 HMG CoA reductase inhibitors 62 CCX# 62 #ME# 62 CCR9 antagonist 62 ALV# 62 mTOR inhibitors 62 MTP inhibitor 62 Factor VIIa 61 5 HT4 receptor 61 novel peptide 61 FGFR 61 SLx 61 Cx# [002] 61 TLR8 agonist 61 AEG# 61 HSP# inhibitor 61 SYN# 61 LNP formulations 61 predictive biomarkers 61 TKM ApoB 61 antisense inhibitor 61 5 HT2C receptor 61 BrachySil TM 61 PSN# [001] 61 investigational humanized monoclonal antibody 61 TRO# 61 Panzem R 61 investigational compounds 61 miRview mets 61 M2 subunit 61 anti CD3 61 Zybrestat 61 VAPRISOL 61 uricase 61 lomitapide 61 HQK 61 Microplasmin 61 Aviptadil 61 GRN# 61 teriflunomide 61 Enzastaurin 61 HER3 61 Src inhibitors 61 targeted antifolate 61 INCB# [003] 61 sodium glucose cotransporter 61 ISIS # 61 resolvins 61 investigational therapies 61 ANGPTL4 61 small molecule inhibitors 61 anti fibrotic 61 IMA# 61 RLY# 61 Anticalins 61 Azedra 61 therapeutic monoclonal antibody 61 Cathepsin S 61 highly selective inhibitor 61 Anticalins R 60 selective receptor agonist 60 histone methyltransferases HMTs 60 anticancer compound 60 Vidaza azacitidine 60 Pimavanserin 60 proteasome inhibitor 60 molecular biomarkers 60 PSN# [002] 60 DNA intercalator 60 enzastaurin 60 beta interferons 60 TG# [003] 60 OXi# 60 humanized antibody 60 A3 adenosine receptor 60 immunological diseases 60 EOquin 60 TLR9 agonist 60 FLT3 60 oral prodrug 60 CINOD 60 selective inhibitors 60 cMET 60 metaglidasen 60 ELND-#/AZD-# 60 genomic biomarker 60 hypoxic tumors 60 Insegia 60 protein tyrosine phosphatase 1B 60 Squalamine 60 ART# 60 intranasal formulation 60 Pertuzumab 60 humanized monoclonal 60 Cethrin R 60 rxRNA 60 epothilones 60 Epanova 60 Xanafide 60 Triolex 60 Protein Kinase C 60 delta isoform 60 preclinical efficacy 60 ALK inhibitor 60 Marqibo TM 60 Dapagliflozin 60 RhuDex ® 60 anticancer therapeutics 60 immunomodulation 60 histone deacetylase HDAC 60 AT1R 60 2 methoxyestradiol 60 DiaPep# 60 FBPase 60 aurora kinase 60 PPARγ 60 HepDirect prodrug 60 SIR Spheres 60 radezolid 60 S/GSK# 60 HoFH 60 lumiliximab 60 SinuNase TM 60 selective immunoproteasome inhibitor 60 IL# PE#QQR 60 direct thrombin inhibitors 60 S. maltophilia 60 COMT inhibitors 60 antiarrhythmic 60 selective agonist 60 Candesartan 60 CCR1 60 chemokine receptor 60 BAY #-# 60 Lp PLA 2 60 PRT# 60 urocortin 2 60 histone deacetylase inhibitor 60 ETBs 60 Chrysalin 60 pradefovir 60 thalidomide Thalomid 60 PDE# inhibitors 60 recombinant FVIII 60 Traficet EN 60 PGL# 59 Anticalin R 59 systemically administered 59 JAK inhibitor 59 thyroid hormone receptor 59 PI3K/mTOR 59 multitargeted 59 G#DT 59 Amplimexon 59 TRIOLEX 59 Lubiprostone 59 Anticalin ® 59 CCR5 receptor antagonist 59 Actimmune ® 59 ischemic tissues 59 transient receptor 59 PPARg 59 druggable 59 siRNAs targeting 59 potent inhibitors 59 isoform selective 59 PDGFR 59 PDE4 inhibitors 59 Bendavia 59 Onconase 59 Smac mimetics 59 antidiabetic drugs 59 AEGR 59 tumor necrosis 59 kinase inhibition 59 HCV protease 59 inhibitor RG# 59 Zarnestra 59 antithrombotic 59 eIF 4E 59 Hypoxia Inducible Factor 59 Nanobodies 59 Aflibercept 59 theranostic 59 Galectin 3 59 microtubule inhibitor 59 atrasentan 59 gefitinib Iressa 59 HCV protease inhibitors 59 thymidylate synthase TS 59 PHX# 59 immunomodulatory properties 59 candidate Gencaro TM 59 orally bioavailable 59 angiogenesis inhibitor 59 P#X# 59 renin inhibitors 59 miRs 59 antihypertensive therapies 59 acetonide FA 59 ESBA# 59 Maribavir 59 prognostic markers 59 EGFR inhibitors 59 eTag assays 59 partial agonist 59 Blinatumomab 59 c MYC 59 PARP inhibition 59 synthetic retinoid 59 anti angiogenic agents 59 PDX pralatrexate 59 pan HDAC inhibitor 59 Olaparib 59 IV Busulfex 59 Nexavar sorafenib 59 CEQ# 59 SinuNase ™ 59 liposomal formulation 59 MAGE A3 ASCI 59 IGF 1R 59 oral kinase inhibitor 59 Fibroblast Growth Factor Receptor 59 Aptivus ® 59 IGF IR 59 TPI ASM8 59 EP #R 59 EGS# 59 androgen receptor AR 59 HDACi 59 siRNA therapeutic 59 Aurora kinase 59 volociximab 59 Seliciclib 59 Nanobody ® 59 Chimigen TM 59 proteasome inhibitors 59 Nanobody 59 TÎ ² 4 59 Dasatinib 59 mecamylamine 59 GAP #B# 59 chemopreventive agents 59 cardioprotective effects 59 peripherally acting 59 cellular immunotherapy 59 alagebrium 59 Cerashield 59 pharmacogenetic testing 59 TriRima 59 p# mitogen activated 59 dutogliptin 59 HDL Mimetic Peptide 59 RELOVAIR ™ 59 mertansine 59 CYT# potent vascular disrupting 59 brivaracetam 59 etanercept Enbrel 59 CRLX# 59 Procoralan 59 ERK1 2 59 fosbretabulin 59 selective antagonist 59 pDCs 59 DNA methylation markers 59 Epidermal Growth Factor Receptor 59 ZOLINZA 59 Monoclonal antibody 59 EGFR HER2 59 ErbB3 HER3 59 immunoregulation 59 Onalta 59 SuperAntibody 59 ATL/TV# 59 clinically validated 59 pro angiogenic 59 ALN TTR 59 insulin sensitizing 59 tranilast 59 chemopreventive agent 59 SIRT2 59 A2 Lp PLA2 58 cathepsins 58 tumor xenograft models 58 IPL# 58 DOS# 58 isotypes 58 extensively metabolized 58 ruxolitinib 58 ADAMTS# 58 Azedra TM 58 allosteric modulator 58 chemically modified siRNA 58 DNA methylation biomarkers 58 Lixivaptan 58 Granulocyte Colony Stimulating Factor 58 Guanilib 58 Sym# 58 GLYX 58 TNF Tumor Necrosis Factor 58 Pyridorin 58 RGB # 58 TNF α 58 EndoTAG 58 TRIOLEX HE# 58 THR beta agonist 58 IRX 2 58 Receptors GPCRs 58 SNT MC# 58 florbetaben 58 PDGF receptor 58 Aurora Kinase 58 Hsp# inhibition 58 SARMs 58 Diabetic Neuropathy 58 G Protein Coupled 58 Solazed TM 58 SAR# [002] 58 Reverse Cholesterol Transport 58 thrombin receptor 58 mTOR kinase 58 Mipomersen 58 NNR Therapeutics 58 depsipeptide 58 rNAPc2 58 gene polymorphisms 58 potent anti angiogenic 58 HMG CoA reductase 58 FK# 58 Apoptone 58 JAK2 inhibitors 58 AQ4N 58 Glypromate 58 ASG 5ME 58 huC# DM4 58 PEGylated anti 58 potent inhibition 58 peptide antigens 58 antiangiogenic 58 histone deacetylases 58 Akt inhibitor 58 Chemokine Receptor 58 midkine 58 HDACs 58 preclinical compounds 58 BRAF inhibitor 58 Sphingomab 58 antifibrotic 58 SPC# [001] 58 selective kinase inhibitor 58 ALN VSP 58 IL 1ß 58 orally dosed 58 regorafenib 58 NMDA antagonists 58 Panzem ® 58 tyrosine kinase inhibitor 58 aripiprazole Abilify 58 nalbuphine ER 58 BrachySil ™ 58 adalimumab Humira 58 haematopoietic 58 diagnostic biomarker 58 TLR9 agonists 58 ALN PCS 58 hyaluronidase enzyme 58 OHR/AVR# 58 hypoxia activated prodrug 58 interferon lambda 58 novel immunomodulatory 58 immunotoxin 58 cell adhesion molecule 58 tizanidine hydrochloride short 58 cholesteryl ester transfer 58 polymerase inhibitors 58 Plicera 58 XL# XL# XL# XL# 58 Angiotensin Converting Enzyme 58 humanized anti 58 FGFR1 58 myeloproliferative disorders 58 SGLT inhibitors 58 5 HT6 58 somatostatin analogue 58 DCCR 58 Atrasentan 58 potently inhibit 58 P#X# antagonist 58 favorable pharmacokinetic profile 58 Deforolimus 58 CDK inhibitor 58 Spiegelmer ® 58 Preclinical studies suggest 58 atacicept 58 oral picoplatin 58 mu opioid receptor antagonist 58 EGFR tyrosine kinase inhibitors 58 tipifarnib 58 NeoLipid TM 58 Ocrelizumab 58 2 inhibitor CYT# 58 phosphorylated proteins 58 PORxin TM 58 neuroprotectant 58 GW# [003] 58 replicon 58 HCD# [002] 58 GPCR targets 58 potent inhibitor 58 panitumumab Vectibix 58 Protelos R 58 enzyme cofactor 58 serine proteases 58 E#F# 58 antimitotic 58 potency selectivity 58 NTDDS 58 EGFR TKIs 58 Survivin antagonist 58 novel VDA molecule 58 vivo potency 57 LEUKINE 57 LPA1 receptor 57 chimeric monoclonal antibody 57 MAXY G# 57 6R BH4 57 cathepsin K inhibitor 57 Sudhir Agrawal D.Phil 57 heparanase 57 humanised antibody 57 PLK1 SNALP 57 Shigamabs ® 57 LY# [002] 57 nicotinic acetylcholine receptor 57 NS5A 57 GAMMAGARD 57 K ras mutations 57 fluvastatin 57 small molecule tyrosine 57 ApoB SNALP 57 peptidic 57 Ridaforolimus 57 Starlix 57 Bicifadine 57 BENICAR HCT 57 Hsp# inhibitors 57 SIRT1 activators 57 BCR ABL inhibitors 57 Tumour Vascular Disrupting Agent 57 EndoTAG TM -1 57 nucleoside analogues 57 labetuzumab 57 bexarotene 57 cancer immunotherapies 57 Thrombin 57 receptor partial agonist 57 PEDF 57 pharmacological chaperone 57 Initiate Clinical Trial 57 CA9 SCAN 57 Clusterin 57 DNA methyltransferases 57 PEGPH# 57 vivo validation 57 Androxal TM 57 C5a 57 Aplidin 57 PNT# 57 Lisofylline 57 effector function 57 annexin V 57 p# inhibitors 57 TLK# 57 darinaparsin ZIO 57 ganetespib 57 PlGF 57 CDK inhibitors 57 anticancer agent 57 Pazopanib 57 lipid lowering therapies 57 CRTH2 57 YONDELIS R 57 Veregen TM 57 pharmacodynamic PD 57 proteoglycan 57 topical ophthalmic 57 Safinamide 57 Wnt signaling pathway 57 SGLT2 inhibitor 57 edifoligide 57 seliciclib CYC# 57 Icatibant 57 GSK3B 57 YONDELIS 57 investigational pharmacologically unique 57 selectively inhibited 57 kallikrein 57 renin inhibitor 57 Immunotherapeutic 57 PLX cells 57 elotuzumab 57 EyeGate 57 PIK3CA 57 epithelial tumors 57 Aliskiren 57 nucleoside analog 57 Alocrest 57 stable nucleic acid 57 DCVax R 57 myeloperoxidase 57 radiolabeled 57 5 HT2A inverse 57 Panzem R NCD 57 Muraglitazar 57 ZFP TF 57 antithrombotic agents 57 splice variants 57 erlotinib Tarceva ® 57 muscarinic 57 RECOTHROM R 57 otelixizumab 57 trodusquemine 57 HDAC inhibition 57 protein kinase inhibitor 57 riociguat 57 pharmacogenetic test 57 Troxatyl 57 Novolimus 57 Rasilez Tekturna 57 Hsp# Inhibitor 57 Fc fusion protein 57 inhibiting tumor 57 OGG1 57 gastrin 57 COX Inhibiting Nitric Oxide 57 CYC# 57 antiangiogenic agent 57 Cytolin R 57 inhibit viral replication 57 REG1 57 IAP inhibitor 57 cleavable linker 57 CDP# 57 thiazolides 57 NNRs 57 Enkephalin 57 modulators SERMs 57 Panzem 57 Vaprisol 57 anticancer compounds 57 PEG SN# 57 romazarit 57 REP# 57 CD# antibody [001] 57 Ganciclovir 57 HCV polymerase 57 cilengitide 57 evaluating tivozanib 57 dextofisopam 57 HuMax 57 BXT # 57 Eculizumab 57 MAb 57 CG# [003] 57 Myolimus 57 LymphoStat B belimumab 57 small molecule activators 57 hyperphenylalaninemia HPA due 57 engineered RAP peptides 57 immunotherapeutics 57 Methylnaltrexone 57 gastro intestinal inflammation 57 HyACT 57 pharmacologic intervention 57 CFTR inhibitors 57 LY# [003] 57 gamma secretase inhibitor 57 NN# [001] 57 muscarinic receptor agonist 57 Cytochrome P# 57 cobiprostone 57 Catena ® 57 antibody MAb 57 Proxinium TM 57 NEUGENE 57 pharmacodynamic effects 57 anti angiogenic drugs 57 IMiDs R 57 telomerase inhibitor 57 cardiometabolic disorders 57 receptor antagonists 57 OncoVEX 57 Interferon alfa 57 FGFR4 57 potently inhibited 57 amikacin 57 NPM1 57 Bucindolol 57 Polymer Microspheres 57 polycythemia vera PV 57 targeted radiotherapeutic 57 immatics 57 CINTREDEKIN BESUDOTOX 57 ErbB3 57 antiangiogenesis 57 enzyme inhibitors 57 ADP receptor antagonist 57 miRNA therapeutics 57 HCV protease inhibitor 57 candidate deforolimus 57 procaspase 3 57 Pradefovir 56 Telatinib 56 sphingosine 1 56 Gamma secretase 56 GRNCM1 56 MYDICAR ® 56 p# inhibitor 56 HDAC inhibitors 56 pediatric acute lymphoblastic 56 PRAECIS 56 TLE3 56 antisense oligonucleotide 56 Myocet 56 corticosteroid dexamethasone 56 erlotinib Tarceva 56 pegylated interferons 56 statin simvastatin 56 IGFBP2 56 KSP inhibitor 56 Cellcept 56 IL #p# 56 OMNARIS Nasal Spray 56 gene loci 56 CCR5 antagonist 56 radiotherapeutic 56 imatinib Gleevec ® 56 clinically validated targets 56 tumor antigens 56 humanized monoclonal antibodies 56 Litx 56 VeriStrat 56 Cardiotoxicity 56 hERG 56 cabozantinib 56 bardoxolone 56 Pyridorin TM 56 DB# [003] 56 nonclinical studies 56 CCL# 56 GV# [001] 56 MAPK pathway 56 ularitide 56 CORT # 56 UVIDEM 56 SERCA2a 56 MyVax ® 56 hematopoietic cells 56 PBMCs 56 fenofibric acid 56 TRAIL receptor antibodies 56 Hedgehog inhibitor 56 co stimulatory molecules 56 tubulin inhibitors 56 Anticalin 56 HDAC6 56 PI3K/Akt pathway inhibitor 56 XmAb# 56 rBChE 56 reversible inhibitor 56 beta secretase inhibitors 56 IGF1R 56 CYP #A# 56 LymphoStat B TM 56 Tesmilifene 56 Adnectin 56 rhIL 7 56 pexiganan 56 PLX MS 56 LHRH receptor positive 56 IMiDs 56 Cyclooxygenase 2 56 rilonacept 56 sargramostim 56 TBC# 56 SCD1 56 PROfusion 56 CD# monoclonal antibody 56 MKC# MT 56 NSCLC tumors 56 UsiRNAs 56 therapeutically relevant 56 mitogen activated ERK kinase 56 HERmark assay 56 transgenic mouse models 56 HGS# 56 CD# CEA 56 Evoltra ® 56 Ambrisentan 56 olmesartan 56 mGlu2 3 56 Sapacitabine 56 GPIIb IIIa 56 Tasimelteon 56 JAK2 56 tkRNAi technology 56 humanized monoclonal antibody 56 GPx 56 Elagolix 56 Present Preclinical Data 56 InterfeRx 56 prognostic biomarker 56 adenoviral 56 HuMax CD# 56 angiotensin receptor blocker ARB 56 activin 56 HER2 expression 56 RH1 56 inhibit angiogenesis 56 Protelos 56 PI3K inhibitor 56 galectins 56 inhibiting angiogenesis 56 molecularly targeted 56 delipidation 56 Febuxostat 56 Recombinant Human 56 factor Xa inhibitors 56 anti CD# antibodies 56 Tolvaptan 56 Abbokinase 56 adenosine receptor 56 miR #a [001] 56 PI3K Akt 56 PEGylated Fab fragment 56 Thiovir 56 cediranib 56 Genasense ® oblimersen 56 TNFalpha 56 angiotensin II receptor 56 FGFR2 56 inhaled AAT 56 R roscovitine 56 JAK#/JAK# 56 CBLC# 56 inverse agonist 56 Onalta ™ 56 MetAP2 56 novel anticancer 56 deforolimus 56 Epigenomics proprietary 56 albumin binding 56 #beta HSD1 56 Kinase inhibitors 56 elvucitabine 56 Iluvien ® 56 PRTX 56 HDAC Inhibitor 56 PSMA ADC 56 PTP 1B 56 Octreolin 56 novel peptides 56 highly selective adenosine 56 Sitagliptin 56 Imprime PGG 56 somatostatin receptors 56 aleglitazar 56 Uvidem 56 NS#/#A protease 56 gamma secretase inhibitors 56 antisense inhibition 56 GFT# 56 VitiGam 56 monoclonal 56 HCV polymerase inhibitors 56 diagnostic biomarkers 56 ERK signaling 56 HGS ETR1 56 Nav#.# 56 Triapine 56 Amrubicin 56 NPC#L# 56 chemoresistant 56 Zolinza 56 canakinumab 56 cardio renal 56 IMC #B 56 tiapamil 56 immune modulatory 56 neuroregenerative 56 AVN# [001] 56 PTPN# 56 recombinant antibodies 56 Epothilones 56 kidney urologic 56 Personalized Immunotherapy 56 neuro protective 56 sulindac 56 NR2B subunit 56 Liprotamase 56 sCD# 56 Fenretinide 56 BCX# 56 Onco TCS 56 Valdoxan 56 Vilazodone 56 Eg5 56 mineralocorticoid receptor 56 Arimidex anastrozole 56 Debio 56 EnzymeRx 56 histone deacetylase HDAC inhibitors 56 galectin 56 biologic therapeutics 56 insulin sensitizer 56 fibrotic disease 56 SECTA therapy 56 Trofex 56 neuronal nicotinic receptors NNRs 56 faropenem 56 vitro assay 56 Kinases 56 cytotoxic agents 56 alpha 2A 56 oral salmon calcitonin 56 Posiphen 56 IAP inhibitors 56 myelofibrosis polycythemia vera 56 PKM2 56 TNFα 56 endothelial activation 56 axitinib 56 reslizumab 56 oncolytic virus therapies 56 molecular imaging radiopharmaceutical 56 Prestara 56 Oral NKTR 56 plasma renin activity 56 PKCi 56 FVIIa 56 epigenetic therapies 56 Dr. Sosne 56 peroxidation 56 cyclooxygenase 56 XmAb 56 VitiGam TM 56 VA# [002] 56 CR# vcMMAE 56 Ceflatonin R 56 Lenalidomide 56 Small Molecule 56 proapoptotic 56 Janus Kinase 56 DU #b 56 liposome encapsulated 56 bioactive lipids 56 posaconazole 56 Davanat 56 R#/MEM # 56 Ophthotech 56 MEK inhibitor RDEA# 56 BioSurgery 55 MGd 55 specific lectin receptors 55 infliximab Remicade 55 Everolimus 55 castrate resistant prostate cancer 55 AZILECT R 55 Selective Electrochemical Tumor Ablation 55 ERK pathway 55 forodesine 55 PI3K 55 NXL# 55 FGFR3 55 peptidomimetic 55 Daclizumab 55 EpCAM 55 Vandetanib 55 Cloretazine 55 SAR# [004] 55 immunomodulatory therapy 55 investigational immunotherapy 55 Vidaza R 55 PNP inhibitor 55 OXIGON TM 55 developing TB4 55 miR #a [002] 55 FGFs 55 tafamidis 55 biomarker assays 55 ERK5 55 ulimorelin 55 bile acid sequestrant 55 HepeX B 55 IMiDs ® 55 small molecule agonists 55 Aurora kinase inhibitor 55 Tissue Factor 55 TCF#L# 55 sapacitabine CYC# 55 serine protease 55 EOquin TM 55 Bavituximab 55 phase IIa clinical 55 investigational monoclonal antibody 55 demonstrated antitumor activity 55 KRAS mutation 55 dacetuzumab 55 Cloretazine VNP#M 55 Y2 receptor 55 E2F Decoy 55 enzyme inhibitor 55 serum antibodies 55 MLN# 55 sorafenib Nexavar 55 PrevOnco 55 Xcytrin R 55 microRNA biomarkers 55 DEB# 55 Presents Preclinical Data 55 ARIKACE ™ 55 XYOTAX TM 55 Locked Nucleic Acid LNA 55 Trophos 55 Immunohistochemical analysis 55 Phase #b/#a clinical 55 epothilone 55 EZN 55 RayBiotech 55 Canvaxin TM 55 leukotriene pathway